Covid19, High Altitude
Conditions
Keywords
Prevalence, Covid-19, SARS-CoV-2, Hight altitude
Brief summary
Since the beginning of 2020, SARS-CoV-2 outbreak spread over the world, conducting in a pandemic state declared by the world health organization in March 2020. Conflicting data have been yet published regarding to the incidence rate of COVID-19 infection in altitude. Mainly based on analysis from national Peru database, some authors argued that COVID-19 disease, as well as case fatality rate was less frequent in altitude. However, epidemiological data are lacking regarding to the prevalence of COVID-19 in altitude, and more specially in high altitude. Aim of this cross-sectional study is to assess the prevalence of seroconversion for the SARS-CoV-2 in the population of La Rinconada, a mining town at 5,100 m, the highest city in the world.
Interventions
DIAGNOSTIC_TESTSARS-CoV-2 rapid diagnostic test (COVID-PRESTO® IgM/IgG, AAZ, Boulogne-Billancourt, France)
Presence of specific SARS-CoV-2 antibodies (IgM or IgG).
Sponsors
Centre d'Expertise sur l'Altitude EXALT
Study design
Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
\- Age \> 18 years.
Exclusion criteria
* Age \< 18 years. * Inability to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Prevalence of seroconversion for SARS-CoV-2. | Through study completion, an average of 1 week |
Secondary
| Measure | Time frame |
|---|---|
| 2. Occupational and environmental exposures associated with SARS-CoV-2 seroconversion. | Through study completion, an average of 1 week |
Countries
Peru
Outcome results
None listed